Engaging healthcare providers to implement HIV pre-exposure prophylaxis

Current Opinion in HIV and AIDS

Volumn 7, Issue 6, 2012, Pages 593-599

  Krakower, Douglas ^a,b   Mayer, Kenneth H ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FENWAY INSTITUTE   (United States)

Author keywords

HIV; implementation; pre exposure prophylaxis; prevention; provider

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ANTIVIRAL THERAPY; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG UTILIZATION; HEALTH CARE PERSONNEL; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INTERPERSONAL COMMUNICATION; INTERVIEW; MALE HOMOSEXUAL; MOTIVATION; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PRE EXPOSURE PROPHYLAXIS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; REWARD; RISK BENEFIT ANALYSIS; TOPICAL TREATMENT; UNSPECIFIED SIDE EFFECT;

ATTITUDE OF HEALTH PERSONNEL; COMMUNICABLE DISEASE CONTROL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; MALE; PROFESSIONAL COMPETENCE;

EID: 84868447453     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283590446     Document Type: Review

References (48)

1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-2599.
2. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-1174.
3. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423-434.
4. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.
5. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012; 367:411-422.
6. Press Release: MTN Statement on decision to discontinue use of tenofovir gel in VOICE, a Major HIV Prevention Study in Women. Microbicides Trial Network. 28 November 2011. http://www.mtnstopshiv.org/node/3909. [Accessed 1 June 2012]
7. White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS 2012; 26:395-405.
8. Maznavi K, Hardy D, Bredeek F. Pre-exposure prophylaxis (PrEP) for HIV: an online survey of HIV healthcare providers evaluating their knowledge, perception, and prescription of PrEP. In 49th Annual Meeting of the Infectious Diseases Society of, America, Boston, MA; 2011.
9. Petroll AE, Mosack KE. Physician awareness of sexual orientation and preventive health recommendations to men who have sex with men. Sex Transm Dis 2011; 38:63-67.
10. Mimiaga MJ, Goldhammer H, Belanoff C, et al. Men who have sex with men: perceptions about sexual risk, HIV and sexually transmitted disease testing, and provider communication. Sex Transm Dis 2007; 34:113-119.
11. Bernstein KT, Liu KL, Begier EM, et al. Same-sex attraction disclosure to healthcare providers among New York City men who have sex with men: implications for HIV testing approaches. Arch Intern Med 2008; 168:1458-1464.
12. From the Centers for Disease Control and Prevention. HIV prevention practices of primary-care physicians: United States, 1992. J Am Med Assoc 1994; 271:261-262.
13. Montano DE, Phillips WR, Kasprzyk D, Greek A. STD/HIV prevention practices among primary care clinicians: risk assessment, prevention counseling, and testing. Sex Transm Dis 2008; 35:154-166.
14. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55:1-17; quiz CE1-CE4.
15. Loeb DF, Lee RS, Binswanger IA, et al. Patient, resident physician, and visit factors associated with documentation of sexual history in the outpatient setting. J Gen Intern Med 2011; 26:887-893.
16. Obedin-Maliver J, Goldsmith ES, Stewart L, et al. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. J Am Med Assoc 2011; 306:971-977.
17. Mayer KH, Bekker LG, Stall R, et al. Comprehensive clinical care for men who have sex with men: an integrated approach. Lancet 2012; 380:378-387.
18. US Department of Health and Human Services, Centers for Disease Control and Prevention. A guide to taking a sexual history. www.cdc.goc/std/treat ment/sexualhistory.pdf. [Accessed 2 July 2012]
19. Makadon HJ, American College of Physicians. The Fenway guide to lesbian, gay, bisexual, and transgender health. Philadelphia: American College of Physicians; 2008. xvii, 526 p. p.
20. Ghanem KG, Hutton HE, Zenilman JM, et al. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect 2005; 81:421-425.
21. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol 2000; 152:99-106.
22. Jones J, Sullivan PS, Stephenson R, Taussig JA. An iPad-based risk assessment tool for PrEP administration: opinions of MSM [Abstract 1757]. 2011 National HIV Prevention Conference. Atlanta: 14-17 August 2011. http://www.2011nhpc.org/search
23. Coverdale JH, Balon R, Roberts LW. Teaching sexual history-taking: a systematic review of educational programs. Acad Med 2011; 86:1590- 1595.
24. Epstein RM, Levenkron JC, Frarey L, et al. Improving physicians' HIV riskassessment skills using announced and unannounced standardized patients. J Gen Intern Med 2001; 16:176-180.
25. Rabin DL, Boekeloo BO, Marx ES, et al. Improving office-based physician's prevention practices for sexually transmitted diseases. Ann Intern Med 1994; 121:513-519.
26. Madan AK, Caruso BA, Lopes JE, Gracely EJ. Comparison of simulated patient and didactic methods of teaching HIV risk assessment to medical residents. Am J Prev Med 1998; 15:114-119.
27. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003; 52:1- 24.
28. Berwick DM, Hackbarth AD. Eliminating waste in US healthcare. J Am Med Assoc 2012; 307:1513-1516.
29. Loewenstein G, Volpp KG, Asch DA. Incentives in health: different prescriptions for physicians and patients. J Am Med Assoc 2012; 307:1375- 1376.
30. Springrose JV, Friedman F, Gumnit SA, Schmidt EJ. Engaging physicians in risk factor reduction. Popul Health Manag 2010; 13:255-261.
31. Desai K, Sansom SL, Ackers ML, et al. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 2008; 22:1829-1839.
32. Juusola JL, Brandeau ML, Owens DK, Bendavid E. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med 2012; 156:541-550.
33. Paltiel AD, Freedberg KA, Scott CA, et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and costeffectiveness. Clin Infect Dis 2009; 48:806-815.
34. Pretorius C, Stover J, Bollinger L, et al. Evaluating the cost-effectiveness of preexposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One 2010; 5:e13646.
35. Walensky RP, Park JE, Wood R, et al. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis 2012; 54:1504-1513.
36. Gold A, Lichtenberg P. Don't call me 'nudge': the ethical obligation to use effective interventions to promote public health. Am J Bioeth 2012; 12:18-20.
37. Blumenthal-Barby JS, Burroughs H. Seeking better healthcare outcomes: the ethics of using the 'nudge'. Am J Bioeth 2012; 12:1-10.
38. Edwards R, Charani E, Sevdalis N, et al. Optimisation of infection prevention and control in acute healthcare by use of behaviour change: a systematic review. Lancet Infect Dis 2012; 12:318-329.
39. Morris ZS, Clarkson PJ. Does social marketing provide a framework for changing healthcare practice? Health Policy 2009; 91:135-141.
40. Holt TA, Thorogood M, Griffiths F, et al. Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. Br J Gen Pract 2010; 60:e137-e143.
41. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003; 362:1225-1230.
42. Charani E, Edwards R, Sevdalis N, et al. Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review. Clin Infect Dis 2011; 53:651-662.
43. Institute of Medicine (US); Olsen LA, Saunders RS, McGinnis JM, editors. Patients charting the course: citizen engagement and the learning health system: workshop summary. Washington (DC): National Academies Press (US); 2011. The National Academies. Available from: http://www.ncbi.nlm.- nih.gov/books/ NBK92072/.
44. Washington AE, Lipstein SH. The Patient-Centered Outcomes Research Institute: promoting better information, decisions, and health. N Engl J Med 2011; 365:e31.
45. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011; CD001431.
46. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010; 121:1768-1777.
47. Menza TW, Hughes JP, Celum CL, Golden MR. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009; 36:547-555.
48. Smith DK, Pals SL, Herbst JH, et al. Development of a Clinical Screening Index Predictive of Incident HIV Infection Among Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr 2012; 60:421-427.